A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol presents a unique way of generating central nervous system cell cultures from embryonic day 17 mouse brains for neuro(immuno)logy research. This model can be analyzed using various experimental techniques, including RT-qPCR, microscopy, ELISA, and flow cytometry.

Abstract

Models of the central nervous system (CNS) must recapitulate the complex network of interconnected cells found in vivo. The CNS consists primarily of neurons, astrocytes, oligodendrocytes, and microglia. Due to increasing efforts to replace and reduce animal use, a variety of in vitro cell culture systems have been developed to explore innate cell properties, which allow the development of therapeutics for CNS infections and pathologies. Whilst certain research questions can be addressed by human-based cell culture systems, such as (induced) pluripotent stem cells, working with human cells has its own limitations with regard to availability, costs, and ethics. Here, we describe a unique protocol for isolating and culturing cells from embryonic mouse brains. The resulting mixed neural cell cultures mimic several cell populations and interactions found in the brain in vivo. Compared to current equivalent methods, this protocol more closely mimics the characteristics of the brain and also garners more cells, thus allowing for more experimental conditions to be investigated from one pregnant mouse. Further, the protocol is relatively easy and highly reproducible. These cultures have been optimized for use at various scales, including 96-well based high throughput screens, 24-well microscopy analysis, and 6-well cultures for flow cytometry and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. This culture method is a powerful tool to investigate infection and immunity within the context of some of the complexity of the CNS with the convenience of in vitro methods.

Introduction

Improving our understanding of the central nervous system (CNS) is critical to improve therapeutic options for many neuroinflammatory and neurodegenerative diseases. The CNS, a complex network of interconnected cells within the brain, spinal cord, and optic nerves, comprises neurons, oligodendrocytes, astrocytes, and their innate immune cells, the microglia1. An in vitro approach can often drastically reduce the number of mice required to perform meaningful research; however, the complex nature of the CNS makes it impossible to recapitulate the in vivo situation using cell lines. Mixed neural cell cultures provide an extremely valuable research tool to investigate neuro(immuno)logy questions in a relevant model, in line with the Replacement, Reduction and Refinement (3Rs) principles2,3.

Thomson et al. described a cell culture method using prenatal spinal cord cells that differentiate into all the aforementioned main CNS cell types4. This system also has synapse formation, myelinated axons, and nodes of Ranvier. The main limitation of this culturing method is that, being spinal cord, it does not usefully model the brain, and the cell yields from embryonic day 13 (E13) spinal cords are constricting. Thus, this limits the number of experimental conditions that can be investigated. Therefore, this study aimed to develop a new cell culture system that recapitulates the characteristics of the brain with increased cell yield to reduce the requirements for animals.

Using Thomson et al. as a starting point, we developed a cell culture model derived purely from prenatal mouse brains. These cultures have the same cell populations, interconnectivity, and treatment options as the spinal cord cultures, except there is less myelination by comparison. However, having a CNS in vitro model with an approximately threefold higher cell yield is more efficient, requiring fewer mice and less time processing embryos. We optimized this unique culture system for multiple downstream applications and scales, including using glass coverslips for microscopy analysis and various sizes of plastic well plates, including 96-well plates for high throughput research.

Protocol

All animal experiments complied with local laws and guidelines for animal use, and were approved by the local Ethical Review Committee at the University of Glasgow. Animals were housed in specific pathogen-free conditions in accordance with the UK Animals Scientific Procedures Act 1986, under the auspices of a UK Home Office Project License. For this study, in-house bred adult C57BL/6J mice were used. The use of young females (8-12 weeks) is recommended due to the higher success rate of pregnancy; males can be reused for multiple rounds of breeding. Figure 1 represents a schematic overview of the described method to generate mixed neuronal and glial cultures.

1. Preparation of the tissue culture consumables

  1. Prepare the plates and/or dishes containing microscopy coverslips inside a Class 2 Safety cabinet. Sterilize all reagents or autoclave to ensure sterility during the culture period.
  2. Add the appropriate volume of BA-PLL (13.2 Β΅g/mL poly-L-lysinehydrobromide [PLL] in boric acid buffer [BA] [50 mM boric acid, 12.5 mM sodium tetraborate, pH 8.5]; see Table of Materials) to each well (1,000 Β΅L/well in a 6-well plate, 100 Β΅L/well in a 96-well plate; volumes are summarized in Table 1). For microscopy coverslips, add 20 mL of BA-PLL to a 9 cm diameter tissue culture dish containing 200 sterile coverslips, and swirl to distribute evenly.
  3. Incubate at 37 Β°C for 1-2 h.
  4. Remove the BA-PLL solution from each well or dish containing microscopy coverslips, and wash by adding 20 mL of sterile water, swirling the coverslips, and then removing the water. Repeat this wash step three times. For a dish containing coverslips, leave sterile water in the tissue culture dish on the final wash to easily remove the coverslips.
  5. Remove as much liquid as possible with a sterile pipette and allow to dry for at least 2 h toΒ overnight.
  6. Store the coated plates at 4 Β°C for up to 2 months.
    NOTE: The prepared boric acid with poly-l-lysine (BA-PLL) solution can be reused up to three time, adding new PLL each time. Store the BA-PLL at 4 Β°C. Dishes are treated with BA-PLL, as the PLL allows the cells to stick down and grow. Without this treatment, the cells will lift after approximately 1 week of culture and no longer be able to differentiate.

2. Dissection of E17 embryonal brains

  1. Co-house one or multiple female mice with a male mouse. Check the females daily for a mucus plug, indicating mating has taken place.
    NOTE: Any "plugged" female mice need to be separated from the male to ensure the correct start date of gestation. Mice can be weighed to confirm pregnancy or monitored visually.
  2. Cull the pregnant mouse at E17 using appropriate methods in compliance with local animal welfare guidance and laws, for example, by raising carbon dioxide (CO2) concentration, a lethal anesthetic overdose, or dislocation of the neck.
    NOTE: The chosen method must not disrupt the embryos. For this study, exposure to a rising concentration of carbon dioxide gas followed by confirmation of death by severing the femoral artery was used to cull pregnant dams.
  3. Place the culled, pregnant mouse on its back on a dissection board; while pinning it down is not required, it might make it easier for inexperienced researchers. Pinch the midline of the abdomen using forceps. Using sharp scissors, cut open the abdomen through the skin and the peritoneum over the midline from the genitalia to the ribcage, being careful not to puncture the uterus.
    1. The mouse uterus has two horns, each typically containing one to five embryos. Remove the uterus containing the embryos from the mother and immediately place it on ice.
  4. Cut through the yolk sack on the side of the placentas, being careful not to damage the embryos, and remove the embryos from their yolk sack.
  5. Immediately decapitate the embryos. Add the decapitated heads into a dish with Hanks' balanced salt solution (HBSS) without calcium (Ca2+) and magnesium (Mg2+) (HBSS-/-) on ice.
    NOTE: If genotyping is required, one can remove the tail at this stage for genetic analysis. When multiple genotypes are expected, the heads of each embryo should be kept separately for culturing.
  6. Using angled forceps, position the head on its side facing left.
  7. Pierce the eye with one edge of the forceps, firmly holding the chin with the other.
  8. Starting at the nape, gently tear the skin of the scalp along the midline toward the tip of the snout.
  9. Entering through the spinal cord, noticeable as a white oval, use the angled forceps to crack open the skull along the midline, exposing the brain.
  10. Gently peel the skull away on the side facing upward, exposing the brain.
  11. Lift the brain out of the skull, disposing of the skull once the brain has been completely removed.
  12. Using the forceps, remove the meninges, which are noticeable as a thin membrane with dense blood vessels.
  13. Place the brains into a bijou (see Table of Materials) containing 2 mL of HBSS-/- on ice.
  14. Repeat steps 2.6 to 2.13 with the remaining brains, adding up to four brains per bijou.
  15. Add 250 Β΅L of 10x trypsin to the bijou and triturate the brains by shaking the bijou. Incubate for 15 min at 37 Β°C.
    NOTE: All steps from this point forward should be performed in a sterile tissue culture hood.
  16. Thaw 2 mL of soybean trypsin (SD) inhibitor (Leibovitz L-15, 0.52 mg/mL trypsin inhibitor from soybean, 40 Β΅g/mL DNase I, 3 mg/mL bovine serum albumin [BSA] fraction V; see Table of Materials) from -20 Β°C by placing it at 37 Β°C.
  17. Add 2 mL of SD inhibitor to each bijou containing brains (per bijou containing up to four brains), shaking the bijou again to disperse it evenly.
    NOTE: SD inhibitor decreases the trypsin activity to prevent unnecessary digestion of the samples and preserve cell viability.
  18. Without centrifugation, remove 2 mL of the supernatant from each bijou and transfer into a 15 mL centrifuge tube, being careful not to transfer cell clumps.
  19. Triturate the remaining cells in the bijou with a 19 G needle attached to a 5 mL syringe by aspirating the suspension twice. This will create a thick mucus-like mixture.
    1. Repeat twice more using a 21 G needle. If there are clumps remaining, triturate once more with the 21 G needle.
  20. Transfer the cells from the bijou to the same 15 mL centrifuge tube (from step 2.18) using a 23 G needle.
  21. Centrifuge at 200 x g at room temperature (RT) for 5 min.
  22. Remove all the supernatant using a 5 mL serological pipette and transfer it to another 15 mL centrifuge tube, being careful not to disturb the loose pellet at the bottom containing the required cells.
  23. Centrifuge the supernatant again at 200 x g at RT for 5 min.
    NOTE: This step is not essential, but if one requires many cells or has few embryos, one could perform this step to recover as many cells as possible from the supernatant.
  24. Using 10 mL of plating media (PM) (49% Dulbecco's modified eagle medium [DMEM], 1% penicillin/streptomycin [Pen/Strep], 25% horse serum, 25% HBSS with Ca2+ and Mg2+ [HBSS+/+]; see Table of Materials), combine and resuspend the two pellets together to create a whole cell suspension.
  25. Count the cells using trypan blue and either a hemocytometer or digital cell counter, and dilute the cell suspension with PM to a concentration of 1.8 x 106 cells/mL.

3. Plating the cells

  1. Add the required volume of the cell suspension to the required format as detailed in Table 1: 1,000 Β΅L per well in 6-well format, 50 Β΅L per well in 96-well format, or 100 Β΅L per coverslip.
  2. Incubate for 2-4 h at 37 Β°C with 5%-7% CO2. Check the cells have adhered using an inverted microscope.
  3. Remove the media and top up with new differentiation media (DM+: DM- including 10 Β΅g/mL insulin. DM-: DMEM, 1% Pen/Strep, 50 nM hydrocortisone, 10 ng/mL biotin, 2.5 mL 100x N1 media supplement; see Table of Materials). Volumes are detailed in Table 1. Press down any floating coverslips using a sterile pipette tip.

4. Maintaining the cultures

NOTE: These cultures require feeding thrice weekly to support optimal growth and differentiation. The cultures will reach optimum health and maturity for experiments on DIV (days in vitro) 21. Cells can be kept in culture for up to 28 days, after which the cultures quickly degenerate.

  1. Three times per week until DIV12, replace part of the supernatant with fresh DM+ by removing 500 Β΅L per well in 6-well format, 50 Β΅L per well in 96-well format, or 500 Β΅L per dish containing three coverslips, and adding 600 Β΅L per well in 6-well format, 60 Β΅L per well in 96-well format, or 600 Β΅L per coverslip dish (Table 1).
  2. Three times per week from DIV13 onwards, replace part of the supernatant with fresh DM- by removing 500 Β΅L per well in 6-well format, 50 Β΅L per well in 96-well format, or 500 Β΅L per dish containing three coverslips, and adding 600 Β΅L per well in 6-well format, 60 Β΅L per well in 96-well format, or 600 Β΅L per coverslip dish (Table 1).

Results

Microscopy
Cultures grown on glass coverslips are ideal to analyze by microscopy. To visualize the development of the cultures, the coverslips were fixed in 4% paraformaldehyde (PFA) at multiple timepoints from DIV0 (once cells were attached) until DIV28. The cultures were stained for immunofluorescence imaging as previously described5 using three different staining combinations: NG2 (immature oligodendrocytes) and nestin (neuronal stem/progenitor cells) as developmental mar...

Discussion

The CNS is a complex network that spans from the brain down to the spinal cord and consists of many cell types, predominantly neurons, oligodendrocytes, astrocytes, and microglia1. As each cell has an important role in maintaining homeostasis and generating appropriate responses to challenges in the CNS9,10,11, a culture system that contains all these cell types is a useful and versatile tool to investiga...

Disclosures

The authors have nothing to disclose.

Acknowledgements

We would like to thank members of the Edgar and Linington labs, particularly Prof. Chris Linington, DrΒ Diana Arseni, and DrΒ Katja Muecklisch, for their advice, helpful comments, and assistance with feeding the cultures while we set up these cultures. Particular thanks go to Dr Muecklisch for providing the starting points for the Cell Profiler pipelines. This work was supported by the MS Society (grant 122) and the Yuri and Lorna Chernajovsky foundation to MP; University of Glasgow funding to JC and MP; and Wellcome Trust (217093/Z/19/Z) and Medical Research Council (MRV0109721) to GJG.

Materials

NameCompanyCatalog NumberComments
10x TrypsinSigmaT4549-100MLTo digest tissue
140 mm TC DishFisher11339283Put 8 35 mm dishes per 1 140 mm dish
15 mL FalconSarstedt62554502To collect cells into pellet for resuspension in plating media
18 G needleHenke Sass Wolf4710012040For trituration of sample
21 G needleBD304432For trituration of sample
23 G needleHenke Sass Wolf4710006030For trituration of sample
35 mm TC DishCorning430165Plate out 3 PLL coated coverslips per 1 35 mm dish
5 mL syringeFisher15869152For trituration of sample
6 well plateCorning3516To plate out cells for RT-qPCR, and flow cytometry
7 mL BijouxFisherDIS080010RTo put brains intp
96 well plateCorning3596To plate out cells for high-throughput testing
ACSA-2 Antibody, anti-mouse, PEMiltenyi130-123-284For flow cytometry staining of astrocytes
Angled forcepsDumont0108-5/45-POFor dissection
BiotinSigmaB4501For DM+/-
Boric AcidSigmaB6768-500GFor boric acid buffer
Brilliant Violet 421 anti-mouse CD24 Antibody, clone M1-69Biolegend101825For flow cytometry staining of neurons and astrocytes
Brilliant Violet 605 anti-mouse CD45 Antibody, clone 30-F11Biolegend103139For flow cytometry staining of microglia
Brilliant Violet 785 anti-mouse/human CD11b Antibody, clone M1/70Biolegend101243For flow cytometry staining of microglia
BSA Fraction VSigmaA3059-10GFor SD Inhibitor
CNPAbcamAB6319Mature oligodendrocytes
CoverslipVWR631-0149To plate out cells for microscopy
Dissection ScissorsSigmaS3146-1EAFor dissection
DMEM High glucose, sodium pyruvate, L-GlutamineGibco21969-035For DM+/-, and for plating media
DNase IThermofisher18047019For SD Inhibitor, can use this or the other Dnase from sigma
DNase ISigmaD4263For SD Inhibitor, can use this or the other Dnase from thermofisher
eBioscience Fixable Viability Dye eFluor 780Thermofisher65-0865-14Live / Dead stain
Fine forcepsDumont0102-SS135-POFor dissection
GFAPInvitrogen13-0300Astrocytes
HBSS w Ca MgSigmaH9269-500MLFor plating media
HBSS w/o Ca MgSigmaH9394-500MLFor brains to be added to
Horse SerumGibco26050-070For plating media
HydrocortisoneSigmaH0396For DM+/-
Iba1Alpha-Laboratories019-1971Microglia
InsulinSigmaI1882For DM+
Leibovitz L-15GIbco11415-049For SD Inhibitor
MBPBio-RadMCA409SMyelin
Mouse CCL5/RANTES DuoSet ELISA KitBioTechneDY478-05ELISA kit for quantifying concentration of CCL5 in supernatants of 96 well plate
N1 media supplementSigmaN6530-5MLFor DM+/-
NestinMerckMAB353Neuronal stem/progenitor cells
NeuNThermofisherPA578499Neuronal cell body
NG2SigmaAB5320Immature oligodendrocytes
O4 Antibody, anti-human/mouse/rat, APCMiltenyi130-119-155For flow cytometry staining of oligodendrocytes
Pen/StrepSigmaP0781-100MLFor DM+/-, and for plating media
Poly-L-LysinehydrobromideSigmaP1274For Boric acid / poly-L-lysine solution to coat coverslips
SMI31BioLegend801601Axons
Sodium TetraborateSigma221732-100GFor boric acid buffer
TrizolThermofisher15596026For lysing cells for RT-qPCR
Trypsin inhibitor from soybeanSigmaT9003-100MGFor SD Inhibitor

References

  1. Kovacs, G. G. Cellular reactions of the central nervous system. Handbook of Clinical Neurology. 145, 13-23 (2018).
  2. Russell, W. M. S., Burch, R. L. . The Principles of Humane Experimental Techniques. 1, (1959).
  3. Hubrecht, R. C., Carter, E. The 3Rs and humane experimental technique: Implementing change. Animals. 9 (10), 754 (2019).
  4. Thomson, C. E., et al. synapsing cultures of murine spinal cord-validation as an in vitro model of the central nervous system. The European Journal of Neuroscience. 28 (8), 1518-1535 (2008).
  5. Bijland, S., et al. An in vitro model for studying CNS white matter: Functional properties and experimental approaches. F1000Research. 8, 117 (2019).
  6. Fragkoudis, R., et al. Neurons and oligodendrocytes in the mouse brain differ in their ability to replicate Semliki Forest virus. Journal of Neurovirology. 15 (1), 57-70 (2009).
  7. Hayden, L., et al. Lipid-specific IgMs induce antiviral responses in the CNS: Implications for progressive multifocal leukoencephalopathy in multiple sclerosis. Acta Neuropathologica Communications. 8 (1), 135 (2020).
  8. Kantzer, C. G., et al. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes. Glia. 65 (6), 990-1004 (2017).
  9. Yin, J., Valin, K. L., Dixon, M. L., Leavenworth, J. W. The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer. Journal of Immunology Research. 2017, (2017).
  10. Gee, J. R., Keller, J. N. Astrocytes: Regulation of brain homeostasis via apolipoprotein E. The International Journal of Biochemistry and Cell Biology. 37 (6), 1145-1150 (2005).
  11. Madeira, M. M., Hage, Z., Tsirka, S. E. Beyond myelination: possible roles of the immune proteasome in oligodendroglial homeostasis and dysfunction. Frontiers in Neuroscience. 16, 867357 (2022).
  12. Keller, D., ErΓΆ, C., Markram, H. Cell densities in the mouse brain: A systematic review. Frontiers in Neuroanatomy. 12, 83 (2018).
  13. Wang, Y. X., et al. Oxygenglucose deprivation enhancement of cell death/apoptosis in PC12 cells and hippocampal neurons correlates with changes in neuronal excitatory amino acid neurotransmitter signaling and potassium currents. Neuroreport. 27 (8), 617-626 (2016).
  14. Rock, K. L., Kono, H. The inflammatory response to cell death. Annual Review of Pathology: Mechanisms of Disease. 3, 99-126 (2008).
  15. Chen, V. S., et al. Histology atlas of the developing prenatal and postnatal mouse central nervous system, with emphasis on prenatal days E7.5 to E18.5. Toxicologic Pathology. 45 (6), 705-744 (2017).
  16. Gordon, J., Amini, S., White, M. K. General overview of neuronal cell culture. Methods in Molecular Biology. 1078, 1-8 (2013).
  17. Kesselheim, A. S., Hwang, T. J., Franklin, J. M. Two decades of new drug development for central nervous system disorders. Nature Reviews Drug Discovery. 14 (12), 815-816 (2015).
  18. Gribkoff, V. K., Kaczmarek, L. K. The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes. Neuropharmacology. 120, 11-19 (2017).
  19. Zamanian, J. L., et al. Genomic analysis of reactive astrogliosis. Journal of Neuroscience. 32 (18), 6391-6410 (2012).
  20. Nishiyama, A., Suzuki, R., Zhu, X. NG2 cells (polydendrocytes) in brain physiology and repair. Frontiers in Neuroscience. 8, 133 (2014).
  21. Lee, C. T., Bendriem, R. M., Wu, W. W., Shen, R. F. 3D brain organoids derived from pluripotent stem cells: Promising experimental models for brain development and neurodegenerative disorders. Journal of Biomedical Science. 24 (1), 59 (2017).
  22. Asch, B. B., Medina, D., Brinkley, B. R. Microtubules and actin-containing filaments of normal, preneoplastic, and neoplastic mouse mammary epithelial cells. Cancer Research. 39 (3), 893-907 (1979).
  23. Koch, K. S., Leffertt, H. L. Growth control of differentiated adult rat hepatocytes in primary culture. Annals of the New York Academy of Sciences. 349, 111-127 (1980).
  24. Nevalainen, T., Autio, A., Hurme, M. Composition of the infiltrating immune cells in the brain of healthy individuals: effect of aging. Immunity and Ageing. 19 (1), 45 (2022).
  25. Daneman, R., Prat, A. The blood-brain barrier. Cold Spring Harbor Perspectives in Biology. 7 (1), 020412 (2015).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Mixed Cell CultureEmbryonic Mouse BrainCentral Nervous SystemInnate ImmunityViral InfectionInterferon BetaThree RsAnimal WelfareCell based AssaysPMLMultiple Sclerosis

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright Β© 2025 MyJoVE Corporation. All rights reserved